The coronavirus pandemic has significantly impacted solid organ transplantation (SOT).
Early in the outbreak period, transplant societies recommended suspending living kidney …

Severe acute respiratory virus syndrome 2 (SARS-CoV-2) has led to a worldwide pandemic.
Early studies in solid organ transplant (SOT) recipients suggested a wide variety of …

COVID-19 is associated with increased morbidity and mortality in transplant recipients.
There are no efficacy data available regarding these patients with any of the available SARS …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated
with a high rate of mortality in patients with ESKD, and vaccination is hoped to prevent …

Rationale & Objective Coronavirus disease 2019 (COVID-19) may be associated with high
rates of acute kidney injury (AKI) and kidney replacement therapy (KRT), potentially …

Kidney transplant recipients receive therapeutic immunosuppression that impairs their
immune responses to the COVID-19 mRNA vaccine. For this reason, this vulnerable patient …

Over the course of the COVID-19 pandemic, numerous studies have aimed to address the
challenges faced by patients with kidney disease and their caregivers. These studies …

The pandemic of coronavirus disease 2019 (CoVID-19) has been an unprecedented period.
The disease afflicts multiple organ systems, with acute kidney injury (AKI) a major …

The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) exploded onto the world stage in early …

The cilgavimab− tixagevimab combination retains a partial in vitro neutralizing activity
against the current SARS‐CoV‐2 variants of concern (omicron BA. 1, BA. 1.1, and BA. 2) …